Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?

Overview Forecast RevenueFinancials Chart

Stoke Therapeutics Ownership Summary

Stoke Therapeutics is owned by 112.30% institutional investors, 4.54% insiders. Skorpios trust is the largest institutional shareholder, holding 12.26% of STOK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.

STOK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Stoke Therapeutics	112.30%	4.54%	-16.84%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Skorpios trust	6.91M	12.26%	$76.18M
Blackrock	5.41M	11.70%	$73.08M
Blackrock funding, inc. /de	5.92M	10.15%	$67.24M
Lynx1 capital management lp	5.19M	9.21%	$57.21M
Rtw investments, lp	5.12M	8.78%	$58.15M
Baker bros. advisors lp	4.63M	7.94%	$52.59M
Morgan stanley	3.48M	7.52%	$47.00M
Redmile group	4.38M	7.50%	$49.67M
Cowen and company	3.37M	7.28%	$45.47M
Toronto dominion bank	3.17M	5.44%	$36.02M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Skorpios trust	6.91M	99.80%	$76.18M
Lynx1 capital management lp	5.19M	21.45%	$57.21M
Redmile group	4.38M	5.29%	$49.67M
Birchview capital, lp	210.00K	2.37%	$2.38M
Dafna capital management	501.97K	1.57%	$5.70M
Bioimpact capital	789.70K	1.55%	$8.96M
Siren	2.25M	1.32%	$25.51M
Cowen and company	3.37M	1.25%	$45.47M
Rtw investments, lp	5.12M	0.83%	$58.15M
Baker bros. advisors lp	4.63M	0.51%	$52.59M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	5.41M	0.00%	1.55M
State street	1.59M	0.00%	1.01M
Polar capital	883.65K	0.05%	883.65K
Assenagon asset management	900.27K	0.03%	362.30K
Norges bank	314.80K	0.00%	314.80K

Top Sellers

Holder	Shares	% Assets	Change
Skorpios trust	6.91M	99.80%	-2.00M
Healthcare of ontario pension plan trust fund	-	-	-1.39M
Logos global management lp	-	-	-1.05M
Checkpoint capital	-	-	-730.72K
Morgan stanley	3.48M	0.00%	-546.21K

New Positions

Holder	Shares	% Assets	Change	Value
Polar capital	883.65K	0.05%	883.65K	$10.03M
Norges bank	314.80K	0.00%	314.80K	$3.47M
Schonfeld strategic advisors	291.80K	0.02%	291.80K	$3.22M
Panagora asset management	104.27K	0.01%	104.27K	$1.15M
Aviva	43.95K	0.00%	43.95K	$498.89K

Sold Out

Holder	Change
Quest partners	-2.00
Nelson, van denburg & campbell wealth management group	-5.00
Ifp advisors	-6.00
Mid-american wealth advisory group	-17.00
Parallel advisors	-24.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	133	4.72%	65,529,807	16.03%	112	1.18%	73	2.82%	33	22.22%
Mar 31, 2025	128	-2.29%	63,381,918	9.17%	109	1.03%	70	4.48%	28	-33.33%
Dec 31, 2024	38	-68.33%	19,005,198	-67.36%	33	0.32%	20	-67.21%	10	-72.22%
Sep 30, 2024	120	3.45%	58,218,197	-5.03%	103	0.59%	61	-25.61%	36	63.64%
Jun 30, 2024	116	5.45%	61,304,739	13.13%	132	0.97%	82	17.14%	22	-15.38%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.61M	2.97%	-
Fidelity Select Biotechnology	1.57M	2.86%	330.59K
Vanguard Total Stock Mkt Idx Inv	1.54M	2.81%	-34.18K
Polar Capital Biotech S Inc	1.25M	2.28%	366.35K
Fidelity Select Health Care	1.20M	2.19%	200.00K
iShares Russell 2000 ETF	992.23K	1.81%	-
Fidelity Stock Selector Small Cap	972.10K	1.77%	-
FIAM Small Cap Core CIT Cl B	871.00K	1.59%	871.00K
BlackRock Health Sciences Opps Inv A	857.19K	1.56%	-68.75K
BGF World Healthscience A2 USD	851.11K	1.56%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 08, 2025	Kaye Edward M. MD	-	Sell	$750.00K
Oct 03, 2025	Kaye Edward M. MD	-	Sell	$1.07M
Oct 03, 2025	Allan Jonathan	GENERAL COUNSEL & CORP SEC	Sell	$250.65K
Oct 01, 2025	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$126.32K
Sep 02, 2025	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$109.33K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	4
2025 Q3	-	13
2025 Q2	-	5
2025 Q1	-	6
2024 Q4	-	11

STOK Ownership FAQ

Who Owns Stoke Therapeutics?

Stoke Therapeutics shareholders are primarily institutional investors at 112.30%, followed by 4.54% insiders and -16.84% retail investors. The average institutional ownership in Stoke Therapeutics's industry, Biotech Stocks , is 307.10%, which Stoke Therapeutics falls below.

Who owns the most shares of Stoke Therapeutics?

Stoke Therapeutics’s largest shareholders are Skorpios trust (6.91M shares, 12.26%), Blackrock (5.41M shares, 11.70%), and Blackrock funding, inc. /de (5.92M shares, 10.15%). Together, they hold 34.11% of Stoke Therapeutics’s total shares outstanding.

Does Blackrock own Stoke Therapeutics?

Yes, BlackRock owns 11.70% of Stoke Therapeutics, totaling 5.41M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 73.08M$. In the last quarter, BlackRock increased its holdings by 1.55M shares, a 40.19% change.

Who is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested?

Skorpios trust is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested, with 99.80% of its assets in 6.91M Stoke Therapeutics shares, valued at 76.18M$.

Who is the top mutual fund holder of Stoke Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Stoke Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.61M Stoke Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools